Skip to main content
Figure 3 | Diagnostic Pathology

Figure 3

From: Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 g ene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Figure 3

Brightfield double in situ hybridization (BDISH) for HER2 and chromosome 17 centromere (CEN 17) on formalin-fixed, paraffin-embedded clinical breast cancer cases. Examples of normal HER2 gene (A), amplified HER2 gene (B), single HER2 gene (C), and chromosome 17 polysomy (D) cases were shown. 100×.

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us